|
|
Volumn 14, Issue 2, 2015, Pages 91-
|
|
Obesity and diabetes: FXR and JAK step up to BAT
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FARNESOID X RECEPTOR;
FARNESOID X RECEPTOR STIMULATING AGENT;
FEXARAMINE;
FIBROBLAST GROWTH FACTOR 19;
HORMONE RECEPTOR STIMULATING AGENT;
JANUS KINASE;
JANUS KINASE 3 INHIBITOR;
UNCLASSIFIED DRUG;
UNCOUPLING PROTEIN 1;
BENZENE DERIVATIVE;
BILE ACID;
CELL RECEPTOR;
FARNESOID X-ACTIVATED RECEPTOR;
FIBROBLAST GROWTH FACTOR;
FIBROBLAST GROWTH FACTOR 15, MOUSE;
BROWN ADIPOCYTE;
BROWN ADIPOSE TISSUE;
DIABETES MELLITUS;
DRUG ABSORPTION;
DRUG EFFECT;
DRUG MECHANISM;
ENZYME INHIBITION;
GLUCOSE INTOLERANCE;
HUMAN;
HYPERCHOLESTEROLEMIA;
NONHUMAN;
NOTE;
OBESITY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN SECRETION;
SIGNAL TRANSDUCTION;
THERMOGENESIS;
WEIGHT GAIN;
WHITE ADIPOCYTE;
AGONISTS;
ANIMAL;
DRUG EFFECTS;
INSULIN RESISTANCE;
INTESTINE;
METABOLISM;
ADIPOSE TISSUE, BROWN;
ANIMALS;
BENZENE DERIVATIVES;
BILE ACIDS AND SALTS;
FIBROBLAST GROWTH FACTORS;
INSULIN RESISTANCE;
INTESTINES;
OBESITY;
RECEPTORS, CYTOPLASMIC AND NUCLEAR;
WEIGHT GAIN;
|
|
EID: 84926022212
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4543 Document Type: Note |
|
Times cited : (9)
|
|
References (2)
|
